Skip to main content

Month: July 2021

Pieridae Announces Resignation of CFO

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR DISSEMINATION IN UNITED STATES CALGARY, Alberta, July 05, 2021 (GLOBE NEWSWIRE) — Pieridae Energy Limited (“Pieridae” or the “Company”) (PEA.TO) today announced that Rob Dargewitcz has resigned as Chief Financial Officer (“CFO”) of the Company, effective July 30, 2021, to pursue other opportunities. The Company noted that Mr. Dargewitcz’s departure is not related to any issues or disagreements regarding Pieridae’s financial disclosures or accounting policies and practices. We thank Mr. Dargewitcz for his service. The Company will soon begin a process to appoint a successor to Mr. Dargewitcz and a further announcement will be made in due course. About Pieridae:Founded in 2011, Pieridae, a majority Canadian owned corporation based in Calgary, is focused on advancing integrated...

Continue reading

Vitalhub Corp. Announces Acquisition of UK Based Alamac Limited

TORONTO, July 05, 2021 (GLOBE NEWSWIRE) — VitalHub Corp. (the “Company” or “VitalHub”) (TSXV: VHI) is pleased to announce today that it has acquired (the “Acquisition”) Alamac Limited (“Alamac”). This is VitalHub’s 11th acquisition completed since 2017 and marks continued expansion into the growing patient flow and operational visibility market. When asked to comment on the acquisition, VitalHub CEO Dan Matlow said: “We are delighted to have acquired Alamac, as we continue to progress and execute on our growth strategy, which includes both M&A and organic growth. Alamac has extensive experience building and implementing robust Patient Flow Business Intelligence systems across the NHS, with offerings that are highly synergistic with our Transforming Systems solutions. We believe our existing install base and prospective customers...

Continue reading

Photon Control Obtains Final Order for Plan of Arrangement

VANCOUVER, British Columbia, July 05, 2021 (GLOBE NEWSWIRE) — Photon Control Inc. (“Photon Control” or the “Company”) (TSX: PHO), a leading developer and supplier of optical measurement technologies and systems, is pleased to announce that it has obtained a final order from the Supreme Court of British Columbia approving the previously announced plan of arrangement (the “Arrangement”) with MKS Instruments, Inc. (“MKS”), pursuant to which MKS, through its wholly-owned subsidiary 1302998 B.C. Ltd. (“B.C. Ltd.”), will acquire all of the issued and outstanding shares of Photon Control in an all-cash transaction (the “Transaction”) valued at approximately $387 million. The Arrangement was previously approved by Photon Control securityholders at the annual general and special meeting of securityholders held on June 29, 2021 (the “Meeting”)....

Continue reading

16/2021 Green Hydrogen Systems A/S – Related party transaction

Company announcement 16/2021 Reporting of transactions made by persons discharging managerial responsibilities and persons closely associated with them in Green Hydrogen Systems’ shares Kolding, Denmark, 5 July 2021 –  Pursuant to the Market Abuse Regulation article 19, Green Hydrogen Systems hereby notifies receipt of information of the following transaction, made by persons discharging managerial responsibilities in Green Hydrogen Systems and persons closely associated with them in Green Hydrogen Systems’ shares and other financial instruments linked thereto: 1. Details of the person discharging managerial responsibilities/person closely associateda) Name Migo ApS2. Reason for the notificationa) Position/status Closely associated person to Simon Krogsgaard Ibsen, member of the board of directors of Green Hydrogen Systems...

Continue reading

Hearing Aids Market Size 2028 | To Reach USD 11.02 Billion by 2028, Exhibiting a CAGR of 7.4 %

Hearing Aids Market to Reach USD 11.02 Billion by 2028; Launch of Starkey’s Next-Generation Livio Edge AI to Bolster Growth: Fortune Business Insights™ Pune, India, July 05, 2021 (GLOBE NEWSWIRE) — The global “hearing aids market” size is expected to reach USD 11.02 billion by 2028, exhibiting a CAGR of 7.4 % during the forecast period. The increasing innovations in hearing technologies coupled with the trend for connected devices will have an incredible impact on the market growth during the forecast period, states Fortune Business Insights, in a report, titled “Hearing Aids Market, 2021-2028.” The market size stood at USD 6.47 billion in 2020 and USD 6.67 billion in 2021. Delayed Cochlear Implantations Procedures to Affect Business amid Coronavirus COVID-19 had a dramatic effect on the healthcare sector. The postponement of...

Continue reading

Saputo to Expand Its Branded Position in the UK and Abroad by Acquiring the Activities of Wensleydale Dairy Products

MONTRÉAL, July 05, 2021 (GLOBE NEWSWIRE) — Saputo Inc. (“we”, “Saputo” or “the Company”) (TSX: SAP) announces today that it has entered into an agreement to acquire the activities of Wensleydale Dairy Products Limited (“Wensleydale Dairy Products”). The business, which will join Saputo’s Dairy Division (UK) under its Europe Sector, operates two facilities located in North Yorkshire and employs approximately 210 people. The purchase price of GBP 23 million (approximately CDN$39 million), on a cash-free and debt-free basis, will be paid in cash at closing. Wensleydale Dairy Products manufactures, blends, markets, and distributes a variety of specialty and regional cheeses, including Yorkshire Wensleydale cheese, which will complement and broaden the Company’s existing range of British cheeses, including Cathedral City and Davidstow...

Continue reading

Brookfield Business Partners to Acquire DexKo Global

BROOKFIELD, NEWS, July 05, 2021 (GLOBE NEWSWIRE) — Brookfield Business Partners L.P. (NYSE:BBU) (TSX:BBU.UN) (“Brookfield Business Partners”) together with institutional partners (collectively “Brookfield”) today announced an agreement to acquire DexKo Global Inc. (“DexKo” or “the Company”) for $3.4 billion. DexKo is a global manufacturer of highly engineered components for trailer, recreational vehicle and towable equipment providers. The Company has a leading presence in its core products across North America, Europe and Australia with vertically integrated production and distribution capabilities and a commitment to sustainability. DexKo manufactures and distributes over 65,000 products including highly engineered, customized solutions for a diverse range of customers across its global footprint. “We are pleased...

Continue reading

Dimensional Fund Advisors Ltd. : Form 8.3 – GCP STUDENT LIVING PLC – Ordinary Shares

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser:   Dimensional Fund Advisors Ltd. (“Dimensional”), in its capacity as investment manager and on behalf its affiliates who are also investment managers. Dimensional and its affiliates expressly disclaim beneficial ownership of the shares described in this form 8.3(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.    (c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate...

Continue reading

TLC Announces Details of Stock Swap Transactions

TAIPEI, Taiwan, July 05, 2021 (GLOBE NEWSWIRE) — Taiwan Liposome Company (Nasdaq: TLC, TWO: 4152, “the company”), a clinical-stage specialty pharmaceutical company developing novel nanomedicines to target areas of unmet medical need, today announced details of the company’s board-approved stock swap transactions with Woods Investment Company, Ltd. (“Woods”) at a press conference held at 4:00pm Taipei time at the Taipei Exchange (TPEx). Details of the stock swap transactions are as follows: In response to the company’s long-term development plan and realization of shareholders’ investment, the company’s board of directors passed a resolution on July 5, 2021, for conducting a stock swap transaction, pursuant to which Woods will issue Series B preferred shares as consideration at NT$100 a share, without adjustment mechanisms...

Continue reading

Botulinum Toxin Market 2026 | Will Reach 8,309.0 Million by 2026, Exhibiting a CAGR of 8.0%

Top Players Covered in the Botulinum Toxin Market Research Report Are Revance Therapeutics, Inc. (California, U.S.), Lanzhou Institute of Biological Products Co., Ltd. (Gansu, China), USWM, LLC. (Kentucky, U.S.), Merz Pharma (Frankfurt, Germany), HUGEL, Inc. (Seoul, Republic of Korea), Galderma (Lausanne, Switzerland), Medytox (Cheongju-si, South Korea), Allergan (Dublin, Ireland) and other key market players. Pune, India, July 05, 2021 (GLOBE NEWSWIRE) — Global Botulinum Toxins Market Size| 2021 Covid-19 Impact On Healthcare Industry Global Analysis By Size, Trends, Growth, Share, Business, Key Players, Merger, Statistics, Competitive Landscape, And Regional Forecast To 2026 is latest study published by Fortune Business Insights. Botulinum Toxins Market | 2021 size will witness considerable growth in the coming years due to the...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.